Teva Pharmaceutical Industries TEVA Peer Comparison

NYSE TEVA
$36.84 +0.08 (+0.22%)
As of: Sep 9, 2026 · 12:05 PM EDT
Peer Comparison

300 Comparable Companies

Industry Generic Drugs

Teva Pharmaceutical Industries Ltd (TEVA) is the 17th largest of 300 Generic Drugs companies by market capitalisation, at 42.93 Bn, behind Revolution Medicines, Inc. at 44.23 Bn. It trades on a P/E of 61.68, 200% above the peer median of 20.58. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 TEVA Teva Pharmaceutical Industries Ltd primary H-04 Pharmaceuticals and Biotechnology HG-01 42.93 Bn 61.68 2.48 39.28 Bn
2 VTRS Viatris Inc primary H-04 Pharmaceuticals and Biotechnology HG-01 19.25 Bn -46.86 1.31 18.36 Bn
3 RDY Dr Reddys Laboratories Ltd primary H-04 Pharmaceuticals and Biotechnology HG-01 9.86 Bn 781.50 2.69 9.69 Bn
4 AMRX Amneal Pharmaceuticals, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 5.52 Bn 25.65 1.77 5.39 Bn
5 BHC Bausch Health Companies Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2.18 0.22 0.55 Bn
6 ANIP Ani Pharmaceuticals Inc primary H-04 Pharmaceuticals and Biotechnology HG-01 1.50 Bn 13.88 1.53 1.14 Bn
7 ALVO Alvotech primary H-04 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -5.36 4.35 1.35 Bn
8 AMPH Amphastar Pharmaceuticals, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 1.00 Bn 11.94 1.36 0.71 Bn
9 FENC Fennec Pharmaceuticals Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -92.67 7.65 0.37 Bn
10 RDHL RedHill Biopharma Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -434.89 37.17 0.18 Bn
11 NTRB NutriBand Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -10.07 43.36 0.07 Bn
12 BGM BGM Group Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.03 Bn — — 0.02 Bn
13 ETST Earth Science Tech, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 6.76 0.72 0.02 Bn
14 NXPL NextPlat Corp primary H-04 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.48 0.51 0.01 Bn
15 COSM Cosmos Health Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.77 0.21 0.01 Bn
16 SCNX Scienture Holdings, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.89 34.79 0.01 Bn
17 AEON AEON Biopharma, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.25 — 0.01 Bn
18 PMHS Polomar Health Services, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.59 1.78 0.01 Bn
19 SXTP 60 Degrees Pharmaceuticals, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.39 2.28 0.00 Bn
20 SBFM Sunshine Biopharma Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.26 0.04 -0.01 Bn
21 QNRX Quoin Pharmaceuticals, Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
22 PRFX PRF Technologies Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.18 53.74 -0.01 Bn
23 GRMLW Greenland Mines Ltd primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 — -0.01 Bn
24 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 647.54 Bn 30.78 6.61 626.78 Bn
25 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 441.45 Bn 69.89 6.86 434.88 Bn
26 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 364.78 Bn 115.11 5.48 357.64 Bn
27 PG PROCTER & GAMBLE Co secondary S-10 Household and Personal Products SG-05 332.95 Bn 20.62 3.83 323.01 Bn
28 NVS Novartis Ag secondary H-01 Pharmaceuticals and Biotechnology HG-01 267.01 Bn 9.27 3.89 259.32 Bn
29 TMO Thermo Fisher Scientific Inc. secondary H-10 Medical Devices and Diagnostics HG-02 224.92 Bn 31.95 4.85 220.86 Bn
30 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 211.88 Bn 24.23 5.56 197.89 Bn
31 ABT Abbott Laboratories secondary H-06 Medical Devices and Diagnostics HG-02 184.57 Bn 34.02 3.96 178.97 Bn
32 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 181.55 Bn -62.71 5.96 178.37 Bn
33 PFE Pfizer Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 158.95 Bn 36.39 2.50 147.25 Bn
34 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 132.31 Bn 30.03 10.51 124.45 Bn
35 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 82.51 Bn 19.06 5.31 74.52 Bn
36 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 61.54 Bn 35.88 11.78 56.36 Bn
37 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 54.69 Bn -17.36 24.55 49.55 Bn
38 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 52.54 Bn 11.27 0.98 45.16 Bn
39 RVMD Revolution Medicines, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 44.23 Bn -25.01 — 44.23 Bn
40 ADM Archer-Daniels-Midland Co secondary S-07 Agribusiness SG-03 41.51 Bn 23.34 0.51 31.94 Bn
41 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 34.07 Bn 43.98 7.09 30.76 Bn
42 KVUE Kenvue Inc. secondary S-11 Household and Personal Products SG-05 34.05 Bn 20.54 2.21 32.94 Bn
43 ALC Alcon Inc secondary H-06 Medical Devices and Diagnostics HG-02 33.97 Bn 52.83 3.16 32.51 Bn
44 KMB Kimberly Clark Corp secondary S-11 Household and Personal Products SG-05 32.68 Bn 18.40 1.97 31.73 Bn
45 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 31.41 Bn 37.63 3.13 30.12 Bn
46 ZTS Zoetis Inc. secondary H-05 Pharmaceuticals and Biotechnology HG-01 30.61 Bn 9.36 3.22 28.93 Bn
47 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 30.10 Bn -20.28 2,755.62 30.10 Bn
48 GEHC GE HealthCare Technologies Inc. secondary H-08 Medical Devices and Diagnostics HG-02 29.92 Bn 14.59 1.41 27.81 Bn
49 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.83 Bn -31.80 24.46 26.67 Bn
50 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.36 Bn 15.73 4.36 20.82 Bn
51 WST West Pharmaceutical Services Inc secondary H-07 Medical Devices and Diagnostics HG-02 23.92 Bn 43.54 7.19 23.48 Bn
52 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 23.55 Bn -13.82 7.61 9.89 Bn
53 CHD Church & Dwight Co Inc /De/ secondary S-10 Household and Personal Products SG-05 22.40 Bn 30.08 3.60 22.15 Bn
54 IFF International Flavors & Fragrances Inc secondary M-02 Chemicals MG-01 21.51 Bn 73.66 2.16 20.94 Bn
55 UTHR UNITED THERAPEUTICS Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 21.31 Bn 16.26 6.76 18.65 Bn
56 STE STERIS plc secondary H-06 Medical Devices and Diagnostics HG-02 21.16 Bn 26.19 3.50 20.68 Bn
57 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.18 Bn 21.46 2.14 17.77 Bn
58 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.96 Bn 18.40 11.26 15.01 Bn
59 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.83 Bn -49.63 12.33 14.99 Bn
60 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.53 Bn 22.02 4.60 15.15 Bn
61 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.13 Bn 16.08 3.29 13.51 Bn
62 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.67 Bn -21.20 20.57 13.95 Bn
63 BWXT BWX Technologies, Inc. secondary I-39 Clean Energy Equipment IG-10 14.48 Bn 40.67 4.12 13.88 Bn
64 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.41 Bn 16.75 5.92 13.57 Bn
65 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.50 Bn — — 12.81 Bn
66 CRL Charles River Laboratories International, Inc. secondary H-11 Pharma Services HG-03 13.34 Bn -56.11 3.33 13.14 Bn
67 BAX Baxter International Inc secondary H-07 Medical Devices and Diagnostics HG-02 12.81 Bn 557.12 1.15 10.66 Bn
68 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.59 Bn 30.45 7.57 12.36 Bn
69 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.52 Bn 171.54 3.67 11.64 Bn
70 CORT Corcept Therapeutics Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 12.29 Bn 226.82 14.80 11.99 Bn
71 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.10 Bn -44.46 18.07 10.50 Bn
72 KYMR Kymera Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 11.40 Bn -38.04 108.54 10.71 Bn
73 CLX Clorox Co /De/ secondary S-10 Household and Personal Products SG-05 10.93 Bn 18.18 1.63 10.79 Bn
74 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
75 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.88 Bn -70.79 14.01 10.56 Bn
76 GKOS GLAUKOS Corp secondary H-06 Medical Devices and Diagnostics HG-02 10.68 Bn -67.82 17.43 10.57 Bn
77 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.20 Bn -26.74 — 9.44 Bn
78 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
79 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.08 Bn 18.83 3.21 9.49 Bn
80 NUVL Nuvalent, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 9.75 Bn -27.07 — 9.75 Bn
81 CYTK Cytokinetics Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 9.74 Bn -13.28 143.91 8.57 Bn
82 PODD Insulet Corp secondary H-06 Medical Devices and Diagnostics HG-02 9.69 Bn 25.82 3.17 9.16 Bn
83 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.61 Bn 86.99 34.06 9.61 Bn
84 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 9.41 Bn -50.01 — 9.41 Bn
85 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.24 Bn -43.53 10.57 7.18 Bn
86 CRNX Crinetics Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 8.99 Bn -17.90 213.22 8.99 Bn
87 CHWY Chewy, Inc. secondary S-04 Branded Foods SG-02 8.71 Bn 34.14 0.68 8.19 Bn
88 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.60 Bn -8.14 — 8.60 Bn
89 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.46 Bn -8.52 51.02 8.10 Bn
90 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.02 Bn -14.89 — 8.02 Bn
91 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.76 Bn 17.57 9.71 7.08 Bn
92 ALKS Alkermes plc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 7.59 Bn 114.81 4.55 6.94 Bn
93 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
94 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.48 Bn -41.79 — 7.48 Bn
95 CELH Celsius Holdings, Inc. secondary S-03 Beverages SG-01 7.20 Bn 120.04 2.36 6.57 Bn
96 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.18 Bn -17.78 — 7.18 Bn
97 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.88 Bn -32.74 28.69 6.55 Bn
98 LNTH Lantheus Holdings, Inc. secondary H-08 Medical Devices and Diagnostics HG-02 6.57 Bn 23.87 4.22 5.98 Bn
99 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.43 Bn -39.46 1.21 6.05 Bn
100 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.38 Bn -28.49 1,025.18 6.38 Bn
101 HIMS Hims & Hers Health, Inc. secondary H-16 Healthcare Providers HG-04 6.37 Bn -44.82 2.47 5.53 Bn
102 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.34 Bn -7.37 10.26 5.90 Bn
103 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.30 Bn -703.30 4,524.98 6.30 Bn
104 BLTE Belite Bio, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 6.21 Bn 0.08 — 6.21 Bn
105 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.20 Bn 76.84 7.37 5.67 Bn
106 TVTX Travere Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 6.18 Bn -142.29 10.46 6.07 Bn
107 LQDA Liquidia Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 6.09 Bn 43.92 13.50 5.80 Bn
108 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.98 Bn -16.17 — 5.98 Bn
109 AMRN Amarin Corp Plc\Uk secondary H-01 Pharmaceuticals and Biotechnology HG-01 5.96 Bn -219.55 31.98 5.64 Bn
110 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.86 Bn — — 4.13 Bn
111 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.86 Bn -16.15 — 5.86 Bn
112 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -33.17 1,163.09 5.66 Bn
113 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.80 Bn 29.39 19.95 4.44 Bn
114 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.62 Bn 14.70 5.57 3.39 Bn
115 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.04 Bn -17.55 — 5.04 Bn
116 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.03 Bn -22.99 — 5.03 Bn
117 FMCQF Fresenius Medical Care AG secondary H-14 Healthcare Providers HG-04 4.79 Bn 4.57 0.17 4.09 Bn
118 ACAD Acadia Pharmaceuticals Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.78 Bn 12.55 4.19 3.82 Bn
119 EWTX Edgewise Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.66 Bn -23.64 — 4.66 Bn
120 DFTX Definium Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.20 Bn -11.88 — 4.20 Bn
121 INDV Indivior Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.05 Bn 11.41 3.04 3.83 Bn
122 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.04 Bn — — 3.63 Bn
123 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn -7.86 1,115.68 4.02 Bn
124 MANE Veradermics, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 4.01 Bn -46.57 — 4.01 Bn
125 BBWI Bath & Body Works, Inc. secondary S-11 Household and Personal Products SG-05 3.90 Bn 5.89 0.53 3.11 Bn
126 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
127 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.86 Bn -7.21 — 3.86 Bn
128 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.86 Bn -18.46 11.87 3.56 Bn
129 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.85 Bn -13.47 372.09 3.85 Bn
130 CPRX CATALYST PHARMACEUTICALS, INC. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn 17.94 6.45 3.09 Bn
131 ELVN Enliven Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn -45.72 — 3.85 Bn
132 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.69 Bn -30.34 — 3.69 Bn
133 TARS Tarsus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.66 Bn -78.05 6.04 3.21 Bn
134 OGN Organon & Co. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.61 Bn 17.26 0.59 2.47 Bn
135 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.60 Bn -35.16 66.87 2.58 Bn
136 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.58 Bn -7.79 30.62 2.88 Bn
137 IPAR Interparfums Inc secondary S-12 Household and Personal Products SG-05 3.58 Bn 17.43 2.38 3.36 Bn
138 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.54 Bn -16.08 15.12 2.71 Bn
139 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.39 Bn -20.57 51.19 3.39 Bn
140 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.23 Bn -6.26 — 3.23 Bn
141 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.14 Bn 110.36 6.78 2.91 Bn
142 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.01 Bn -9.80 19,070.80 3.01 Bn
143 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -11.06 593.06 2.47 Bn
144 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -28.43 — 2.96 Bn
145 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn -14.62 — 2.94 Bn
146 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.92 Bn -8.55 79.36 2.47 Bn
147 NAMS NewAmsterdam Pharma Co N.V. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.90 Bn -11.17 407.13 2.90 Bn
148 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.83 Bn -15.03 6.29 2.12 Bn
149 CURLF Curaleaf Holdings, Inc. secondary S-09 Tobacco and Cannabis SG-04 2.72 Bn -22.95 2.08 2.63 Bn
150 WDFC Wd 40 Co secondary S-10 Household and Personal Products SG-05 2.68 Bn 30.04 3.97 2.62 Bn
151 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.63 Bn -81.01 — 2.63 Bn
152 MLYS Mineralys Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.62 Bn -7.51 — 2.62 Bn
153 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.62 Bn 4.56 0.06 -3.18 Bn
154 TRVI Trevi Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.61 Bn -61.82 — 2.61 Bn
155 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn -8.40 48.85 2.54 Bn
156 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.54 Bn -171.60 10.11 2.43 Bn
157 BEIGF BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
158 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.47 Bn -6.17 — 2.47 Bn
159 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.45 Bn -20.61 44.88 1.77 Bn
160 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -28.61 3.09 2.06 Bn
161 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.43 Bn 13.64 2.53 1.63 Bn
162 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.42 Bn -6.05 34.03 2.42 Bn
163 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.35 Bn -17.11 1.19 1.55 Bn
164 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.33 Bn -37.44 12.35 2.22 Bn
165 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.31 Bn -5.99 4.31 1.95 Bn
166 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -21.22 13.51 2.29 Bn
167 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.25 Bn -3.84 — 1.99 Bn
168 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.22 Bn -11.19 — 1.85 Bn
169 PVLA Palvella Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.19 Bn -41.35 — 1.88 Bn
170 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 12.97 4.21 2.02 Bn
171 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.17 0.34 0.65 Bn
172 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn -2,975.41 — 2.15 Bn
173 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.14 Bn -8.84 — 2.14 Bn
174 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.12 Bn -15.43 105.83 2.12 Bn
175 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 6.67 6.73 1.65 Bn
176 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.07 Bn -5.03 21.06 2.07 Bn
177 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.05 Bn -4.92 2,045.15 2.05 Bn
178 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.00 Bn -13.35 53.95 1.73 Bn
179 PRGO PERRIGO Co plc secondary S-11 Household and Personal Products SG-05 2.00 Bn -1.15 0.48 1.60 Bn
180 SPB Spectrum Brands Holdings, Inc. secondary S-04 Branded Foods SG-02 1.99 Bn 23.53 0.69 1.73 Bn
181 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.99 Bn -5.05 — 1.99 Bn
182 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.96 Bn -9.43 71.00 1.67 Bn
183 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.92 Bn -11.75 18.28 1.54 Bn
184 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.92 Bn -14.36 1,473.61 1.92 Bn
185 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.81 Bn -7.20 5.97 1.81 Bn
186 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn -9.78 7.03 1.22 Bn
187 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.76 Bn -97.45 4.09 0.88 Bn
188 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn -124.42 17.57 1.74 Bn
189 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
190 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -3.31 31.35 1.17 Bn
191 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -6.27 — 1.11 Bn
192 ETON Eton Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.64 Bn 171.80 16.36 1.61 Bn
193 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.64 Bn -26.30 — 1.28 Bn
194 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.61 Bn -8.70 — 1.61 Bn
195 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.61 Bn -6.49 3.88 0.89 Bn
196 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -66.91 8.02 1.31 Bn
197 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -10.35 524.82 1.59 Bn
198 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
199 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.56 Bn -186.21 905.74 1.56 Bn
200 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -9.11 20.12 1.26 Bn
201 INVA Innoviva, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.54 Bn 7.84 2.99 0.96 Bn
202 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -18.03 — 1.51 Bn
203 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -3.23 2.08 1.20 Bn
204 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -13.93 73.88 1.48 Bn
205 LBRX Lb Pharmaceuticals Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -24.09 — 1.46 Bn
206 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -9.45 50.66 0.82 Bn
207 XERS Xeris Biopharma Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -84.47 4.32 1.33 Bn
208 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.44 Bn -26.51 5.56 1.03 Bn
209 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -8.68 — 1.42 Bn
210 HROW Harrow, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -42.26 5.13 1.33 Bn
211 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -4.75 — 1.41 Bn
212 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.39 Bn -9.37 — 1.39 Bn
213 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 80.63 35.82 1.38 Bn
214 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -11.35 880.17 1.17 Bn
215 NMAX Newsmax Inc. secondary C-05 Advertising and Media CG-02 1.37 Bn -17.20 8.92 1.32 Bn
216 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -9.79 — 1.36 Bn
217 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn -8.55 — 1.34 Bn
218 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.32 Bn -6.47 — 1.32 Bn
219 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.29 Bn -5.34 155.27 0.79 Bn
220 HLF Herbalife Ltd. secondary S-11 Household and Personal Products SG-05 1.28 Bn 5.05 0.25 0.91 Bn
221 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -1.39 — 1.28 Bn
222 IART Integra Lifesciences Holdings Corp secondary H-06 Medical Devices and Diagnostics HG-02 1.25 Bn -172.50 0.76 0.98 Bn
223 EPC EDGEWELL PERSONAL CARE Co secondary S-11 Household and Personal Products SG-05 1.24 Bn -17.93 0.55 0.85 Bn
224 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn -12.05 51.49 1.24 Bn
225 MGTX MeiraGTx Holdings plc secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.23 Bn 7.47 3.08 1.09 Bn
226 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -27.97 3.10 1.11 Bn
227 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -25.48 — 1.00 Bn
228 OPK Opko Health, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.19 Bn -31.29 2.02 0.88 Bn
229 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -7.71 — 1.18 Bn
230 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -20.47 — 1.18 Bn
231 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -4.72 23.40 0.68 Bn
232 OLMA Olema Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.11 Bn -5.42 — 1.11 Bn
233 KURA Kura Oncology, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.08 Bn -4.53 13.97 1.08 Bn
234 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.04 Bn -3.92 — 0.50 Bn
235 MRVI Maravai Lifesciences Holdings, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 1.04 Bn -7.61 4.96 0.97 Bn
236 RAJAF TFA Therapeutics, Inc. secondary S-11 Household and Personal Products SG-05 1.02 Bn — 819.11 1.02 Bn
237 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.59 0.92 Bn
238 PCRX Pacira BioSciences, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 69.00 1.35 0.76 Bn
239 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -4.85 15.01 0.61 Bn
240 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -69.78 — 0.91 Bn
241 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.96 Bn -118.02 — 0.96 Bn
242 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -14.19 3.92 0.65 Bn
243 LXRX Lexicon Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -15.13 22.94 0.76 Bn
244 DSGN Design Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -11.76 — 0.74 Bn
245 SGP SpyGlass Pharma, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.93 Bn -48.72 — 0.93 Bn
246 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.92 Bn -16.50 2.04 0.64 Bn
247 ODD Oddity Tech Ltd secondary S-12 Household and Personal Products SG-05 0.92 Bn 12.54 1.24 0.62 Bn
248 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.90 Bn -4.41 — 0.90 Bn
249 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.84 8.45 0.49 Bn
250 QDEL QuidelOrtho Corp secondary H-08 Medical Devices and Diagnostics HG-02 0.88 Bn — — 0.76 Bn
251 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 2.72 3.16 0.78 Bn
252 AVR Anteris Technologies Global Corp. secondary H-06 Medical Devices and Diagnostics HG-02 0.84 Bn -10.15 376.42 0.84 Bn
253 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn -10.51 101.77 0.84 Bn
254 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.83 Bn -8.23 — 0.83 Bn
255 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.82 Bn -15.17 818.91 0.82 Bn
256 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -6.99 9.20 0.67 Bn
257 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.77 Bn -10.15 42.05 0.44 Bn
258 COLL Collegium Pharmaceutical, Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.77 Bn 16.02 0.95 0.62 Bn
259 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.77 Bn -123.63 2.31 0.61 Bn
260 PHAT Phathom Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -7.56 3.10 0.56 Bn
261 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -6.33 — 0.74 Bn
262 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 12.55 5.37 0.51 Bn
263 GYRE Gyre Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.71 Bn -38.37 5.93 0.65 Bn
264 IVEVF Inventiva S.A. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 7.19 132.94 0.69 Bn
265 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -6.24 — 0.62 Bn
266 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn 3.02 1.72 0.59 Bn
267 EVO Evotec SE secondary H-11 Pharma Services HG-03 0.65 Bn — — 0.22 Bn
268 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 5.09 1.71 0.38 Bn
269 AQST Aquestive Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -8.18 11.83 0.54 Bn
270 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 512.03 8.51 0.32 Bn
271 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -16.33 1,032.29 0.56 Bn
272 HELE Helen Of Troy Ltd secondary D-06 Household Durables DG-02 0.63 Bn -1.53 0.35 0.61 Bn
273 EVOH EvoAir Holdings Inc. secondary I-14 Construction Products IG-03 0.63 Bn -56.89 1,861.02 0.62 Bn
274 MPLT MapLight Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.62 Bn -3.07 — 0.62 Bn
275 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.62 Bn -3.79 595.36 0.45 Bn
276 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -8.32 — 0.61 Bn
277 HNST Honest Company, Inc. secondary S-11 Household and Personal Products SG-05 0.61 Bn -50.20 1.79 0.50 Bn
278 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -344,077.60 — 0.60 Bn
279 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -2.99 — 0.37 Bn
280 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -9.71 — 0.59 Bn
281 DCTH Delcath Systems, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.58 Bn 1,174.84 6.08 0.48 Bn
282 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -6.73 — 0.58 Bn
283 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -11.87 — 0.57 Bn
284 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 61.52 1.81 0.00 Bn
285 BWMX Betterware De Mexico, S.A.P.I. De C.V secondary S-12 Household and Personal Products SG-05 0.57 Bn 10.09 0.57 0.54 Bn
286 EOLS Evolus, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -16.63 1.80 0.53 Bn
287 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.74 3.41 0.43 Bn
288 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.55 Bn -6.56 2.30 0.30 Bn
289 NVCT Nuvectis Pharma, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -18.13 — 0.55 Bn
290 IRD Opus Genetics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -5.57 54.98 0.45 Bn
291 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.53 Bn -15.46 336.78 0.42 Bn
292 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.53 Bn -4.59 — 0.53 Bn
293 SPRY ARS Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -2.37 4.48 0.38 Bn
294 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -11.65 13.41 0.46 Bn
295 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -7.58 22.77 0.23 Bn
296 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn -10.27 78.36 0.26 Bn
297 CNTN Canton Strategic Holdings, Inc. secondary T-58 Fintech TG-09 0.49 Bn -5.93 330.55 0.49 Bn
298 CYPH Cypherpunk Technologies Inc. secondary T-58 Fintech TG-09 0.48 Bn 8.09 — 0.48 Bn
299 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -10.97 8.84 0.19 Bn
300 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.21 2.47 0.40 Bn